2021
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension
Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Garcia-Tsao G, Hall SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB, Consortium A. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. Clinical Gastroenterology And Hepatology 2021, 20: 1636-1662.e36. PMID: 34274511, PMCID: PMC8760361, DOI: 10.1016/j.cgh.2021.07.018.Peer-Reviewed Original ResearchConceptsPortal hypertensionTIPS creationInterventional radiologistsTransjugular intrahepatic portosystemic shuntTransjugular intrahepatic portosystemic shunt (TIPS) creationPrevention of complicationsIntrahepatic portosystemic shuntCrucial therapeutic optionPortosystemic Shunt CreationPractice-based recommendationsUse of TIPSTIPS indicationGastrointestinal bleedingHepatic hydrothoraxHepatic encephalopathySignificant morbidityPortosystemic shuntTherapeutic optionsTransplant surgeryConsensus statementTherapeutic decisionsHypertensionApproach groupTherapeutic approachesShunt creation
2017
Predictors of Waitlist Mortality in Portopulmonary Hypertension
DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN. Predictors of Waitlist Mortality in Portopulmonary Hypertension. Transplantation 2017, 101: 1609-1615. PMID: 28207639, PMCID: PMC5481480, DOI: 10.1097/tp.0000000000001666.Peer-Reviewed Original ResearchMeSH KeywordsArterial PressureCause of DeathChi-Square DistributionDatabases, FactualDecision Support TechniquesFemaleHumansHypertension, PortalHypertension, PulmonaryKaplan-Meier EstimateLiver DiseasesLiver TransplantationMaleMiddle AgedMultivariate AnalysisPortal PressurePredictive Value of TestsProportional Hazards ModelsPulmonary ArteryPulmonary CirculationRetrospective StudiesRisk AssessmentRisk FactorsSeverity of Illness IndexTime FactorsTissue and Organ ProcurementTreatment OutcomeVascular ResistanceWaiting ListsConceptsPortopulmonary hypertensionWaitlist mortalityMELD exceptionsLiver diseaseException scoreEnd-Stage Liver Disease (MELD) exception pointsSignificant predictorsCox proportional hazards modelMELD exception scoreWaitlist mortality riskRetrospective cohort studyPulmonary arterial pressureTransplantation Network databaseSignificant univariate predictorsOnly significant univariate predictorsProportional hazards modelMELD scorePosttransplant mortalityPulmonary hypertensionCohort studyArterial pressureUnivariate predictorsC-statisticMortality riskHazards model
2006
Model for end‐stage liver disease (MELD) exception for portopulmonary hypertension
Krowka MJ, Fallon MB, Mulligan DC, Gish RG. Model for end‐stage liver disease (MELD) exception for portopulmonary hypertension. Liver Transplantation 2006, 12: s114-s116. PMID: 17123283, DOI: 10.1002/lt.20975.Peer-Reviewed Original Research